Skip to main content

Table 2 Clinical data before and after RTX of the 8 individual patients

From: Efficacy and safety of low-dose rituximab as induction therapy for antineutrophil cytoplasmic antibody-associated vasculitis with renal involvement: a Chinese case series

No

Age

Sex

Onset or relaps

Lung involvemen

Cr before / after RTX (umol/L)

Alb before / after RTX (g/L)

Urine protein before / after RTX (g/d)

ANCA titer before / after RTX (U/ml)

BVAS before/after RTX

CD19 + B cells Before / 1 months after X (/μL)

Corticosteroids, PE and IVIG

Follow-up period

SAEs during the follow-up period

1

68

F

Onset

No

188.0 /97.7

23.0 / 34.9

8.9 / 0.13

Anti-MPO, 86 / neg

17/0

204/16

P 1 mg/kg before RTX; 0.5 mg/kg from RTX, No PE or IVIG

1 year

none

2

63

F

Onset

No

838.4 / 113.7

25.0 / 44.0

2.7 /0.09

Anti-MPO, 49 / neg

14/0

333/5

P 1 mg/kg before RTX; 0.5 mg/kg from RTX. No PE.IVIG for 20 g*5d, twice

1 year

none

3

67

M

Onset

No

443.9 / 146.7

27.7 / 39.5

1.05 / 0.40

Anti-MPO, 43 / neg

25/12

302/3

P 1 mg/kg before RTX; 0.5 mg/kg from RTX.PE for 5 times.IVIG for 20 g*5d

1 year

none

4

59

M

Relapse

alveolar hemorrhage

182.4 / 295.0

32.7 / 27.7

4.04 / 1.95

Anti-MPO, 55 / 76 (relapsed again at 11 months after RTX)

20/18

137/0

P 10 mg/d. PE for 5 times. No IVIG

1 year

Curable pneumonia at 11 months after RTX

5

75

F

Onset

NO

565.2 / 243.0

30.4 / 45.9

1.37 / 0.286

Anti-MPO, 136, neg

14/12

455/2

P 1 mg/kg before RTX; 0.5 mg/kg from RTX. No PE. IVIG for 20 g*5d

1 year

none

6

70

F

Relapse

NO

162.8 / 157.1

21.0 / 34.0

0.74 / 2.98

Anti-MPO, > 200, neg

18/12

709/2

P 1 mg/kg before RTX; 0.5 mg/kg from RTX. No PE or IVIG

1 year

none

7

32

M

Onset

Pulmonary consolidation

159.3 / 89.3

28.6 / 48.1

2.58 / 0.27

Anti-MPO, 100, 27

19/4

315/3

MP 500 mg*3. P 1 mg/kg before RTX; 0.5 mg/kg from RTX. No PE or IVIG

6 months

none

8

58

F

Onset

Interstitial Pneumonitis

347.7 / 124.5

33.2 / 45.1

1.07 / 0.09

Anti-MPO, 136, neg

13/8

NA/0

P 1 mg/kg before RTX; 0.5 mg/kg from RTX. PE for 6 times. No IVIG

6 months

none

  1. MP methylprednisolone, P prednisolone, PE plasma exchange, RTX rituximab, IVIG intravenous immunoglobulin. Data after RTX means data at last follow-up at 6 months or 1 year after RTX